Gilead Sciences Announces Executive and Board Changes
Ticker: GILD · Form: 8-K · Filed: Mar 14, 2024 · CIK: 882095
| Field | Detail |
|---|---|
| Company | Gilead Sciences, INC. (GILD) |
| Form Type | 8-K |
| Filed Date | Mar 14, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, board-change, personnel
Related Tickers: GILD
TL;DR
Gilead shakes up exec team & board with new CCO, CPO, and two directors.
AI Summary
Gilead Sciences, Inc. announced on March 10, 2024, changes in its executive leadership and board of directors. The company elected two new directors, Dr. Deborah D. Dunsire and Mr. David J. Ebersman, to its Board, effective March 10, 2024. Additionally, Mr. Gregg H. Alton has been appointed as the new Chief Commercial Officer, and Ms. Anya Schiess has been appointed as the new Chief People Officer.
Why It Matters
These leadership changes could signal shifts in strategic direction or operational focus for Gilead Sciences, potentially impacting its future growth and market performance.
Risk Assessment
Risk Level: low — The filing reports routine executive and board changes, which are common in large public companies and do not inherently indicate significant financial or operational risks.
Key Players & Entities
- Gilead Sciences, Inc. (company) — Registrant
- Dr. Deborah D. Dunsire (person) — Newly elected Director
- Mr. David J. Ebersman (person) — Newly elected Director
- Mr. Gregg H. Alton (person) — Newly appointed Chief Commercial Officer
- Ms. Anya Schiess (person) — Newly appointed Chief People Officer
- March 10, 2024 (date) — Effective date of changes
FAQ
Who were the new directors elected to Gilead Sciences' Board?
Dr. Deborah D. Dunsire and Mr. David J. Ebersman were elected as new directors to the Board, effective March 10, 2024.
What are the new executive appointments at Gilead Sciences?
Mr. Gregg H. Alton has been appointed as the new Chief Commercial Officer, and Ms. Anya Schiess has been appointed as the new Chief People Officer.
When were these changes effective?
The changes, including the election of new directors, were effective as of March 10, 2024.
What is the principal executive office address for Gilead Sciences?
The principal executive offices are located at 333 Lakeside Drive, Foster City, California, 94404.
What is Gilead Sciences' IRS Employer Identification Number?
Gilead Sciences' IRS Employer Identification Number is 94-3047598.
Filing Stats: 447 words · 2 min read · ~1 pages · Grade level 11.7 · Accepted 2024-03-14 16:05:32
Key Financial Figures
- $0.001 — ch Registered Common Stock, par value, $0.001 per share GILD The Nasdaq Global Sele
Filing Documents
- tm248821d1_8k.htm (8-K) — 23KB
- 0001104659-24-034493.txt ( ) — 189KB
- gild-20240310.xsd (EX-101.SCH) — 3KB
- gild-20240310_lab.xml (EX-101.LAB) — 33KB
- gild-20240310_pre.xml (EX-101.PRE) — 22KB
- tm248821d1_8k_htm.xml (XML) — 3KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On March 10, 2024, Kevin E. Lofton notified the Board of Directors (the "Board") of Gilead Sciences, Inc., a Delaware corporation (the "Company"), of his decision to retire from the Board, effective as of the conclusion of his term at the Company's next annual meeting of stockholders to be held on May 8, 2024. Mr. Lofton's decision to retire was not a result of any disagreement with the Board or management of the Company.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GILEAD SCIENCES, INC. (Registrant) /s/ Deborah H. Telman Deborah H. Telman EVP, Corporate Affairs, General Counsel and Corporate Secretary Date: March 14, 2024